SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-250816
Filing Date
2023-10-04
Accepted
2023-10-04 17:15:33
Documents
12
Period of Report
2023-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d548055d8k.htm   iXBRL 8-K 26414
  Complete submission text file 0001193125-23-250816.txt   148169

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20230928.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20230928_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20230928_pre.xml EX-101.PRE 11262
6 EXTRACTED XBRL INSTANCE DOCUMENT d548055d8k_htm.xml XML 3341
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 231308903
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences